Within a healthcare system, clinical pharmacists are drug therapy experts, and routinely provide medication therapy evaluations and recommendations to patients and other healthcare professionals. Clinical pharmacists working in the specialty pharmacy sector are the experts for complex chronic medical conditions including HIV, oncology, multiple sclerosis, transplant, hepatitis C, rheumatoid arthritis and hemophilia.
The specialty drugs used to manage chronic conditions are classified as complex medications with unique pharmacology profiles that require special handing and monitoring. Adherence to these life-saving medications is essential. Non-adherence leads to:
. Why? Specialty medications are expensive and often come with complex regimens. Lack of education, a fear of adverse events and side effects, or simply a negative attitude toward medications can also be reasons for non-compliance.
To combat these barriers and promote adherence to medications for chronic disease states, many pharmacies have implemented disease management programs.
As an oncology clinical pharmacist, my daily routine involves managing patients enrolled in . This means ensuring financial assistance for their medications, and providing clinical support and education throughout their course of therapy to ensure patient safety, minimize side effects and promote adherence to achieve optimal clinical outcomes.
On any given day as a clinical pharmacist, I have to act as a research analyst… a pharmacokinetic guru… a patient advocate… or an educational psychologist.
Let’s take a look at each of these roles by starting with where all clinical decisions for patients begin – the prescription.
The above prescription is for the oral oncology medication Tarceva. A clinical pharmacist ensures the medication prescribed is appropriate for Mr. Jones based on his diagnosis. Thus, an oncology clinical pharmacist would need to stay current with the treatment guidelines for NSCLC and have knowledge that Tarceva is indeed one of the first-line agents recommended for the treatment of patients with NSCLC with positive EGFR mutations.
A pharmacokinetic guru has the clinical knowledge to understand that the absorptive property of this drug requires that the patient takes this medication on an empty stomach (1 hour before or 2 hours after a meal). If Mr. Jones consumed this medication with food still in his digestive tract, bioavailability increases to almost 100%, which can make the drug toxic and lead to Mr. Jones experiencing unwarranted side effects.
You might also like
Hats off to you--Strong womanby inca25abcdefghijkl
My point is that I went to the hospital in plenty of time to receive pain medication. I expected it and should have received it on request in a timely manner. I am a clinical pharmacist and I work in a hospital (not this one). There should be enough staff and experts there to provide pain relief for those in need. There is no reason that ANYONE who is in pain, no matter who it is, should have to be in pain in a hospital setting. That is what I believe is negligence. Of course, I am happy that my child is healthy. What I want is for no one to have to go through what I went through. I did not want a natural childbirth
Clinical Pharmacist's Guide to Biostatistics and Literature Evaluation
Book (American College of Clinical Pharmacy)
Pharmacist Provider Status — Pharmacy Times
In 2000, North Carolina was able to pass legislation that created a clinical pharmacist practitioner (CPP). We were able to work with the medical director for Medicare's Fiscal Intermediate to allow a CPP to bill for medical care as a provider.
The Pharmacist's Guide to Evidence-Based Medicine for Clinical Decision Making
Drug Information: A Guide for Pharmacists, Fourth Edition (Drug Information (McGraw-Hill))
Book (McGraw-Hill Medical)
Communication Skills for Pharmacists: Building Relationships, Improving Patient Care
Book (American Pharmacists Association)
Clinical Skills for Pharmacists: A Patient-Focused Approach, 3e (Tietze, Clinical Skills for Pharmacists)